300584 海辰藥業
按盤價 
41.000 +2.780 (+7.274%)
41.000 +2.780 (+7.274%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.635 | 4.051 | 4.001 | 3.748 | 3.414 |
| 總資產報酬率 ROA (%) | 1.133 | 2.807 | 2.799 | 2.687 | 2.500 |
| 投入資產回報率 ROIC (%) | 1.278 | 3.119 | 3.027 | 2.904 | 2.674 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.445 | 82.512 | 83.151 | 81.346 | 75.304 |
| 營業利潤率 (%) | 9.484 | 6.913 | 8.289 | 7.588 | 5.718 |
| 息稅前利潤/營業總收入 (%) | 10.253 | 8.035 | 9.938 | 8.699 | 6.665 |
| 淨利潤/營業總收入 (%) | 10.187 | 6.070 | 7.963 | 7.013 | 6.102 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 120.519 | 172.871 | 121.168 | 112.609 | 125.643 |
| 價值變動淨收益/利潤總額(%) | -9.804 | -55.573 | 0.008 | 0.106 | 3.229 |
| 營業外收支淨額/利潤總額(%) | -1.478 | 1.927 | -1.896 | -4.254 | -4.605 | 償債能力分析 |
| 流動比率 (X) | 1.067 | 1.042 | 1.065 | 0.943 | 1.193 |
| 速動比率 (X) | 0.828 | 0.834 | 0.810 | 0.739 | 0.991 |
| 資產負債率 (%) | 27.136 | 28.213 | 29.113 | 29.908 | 26.537 |
| 帶息債務/全部投入資本 (%) | 21.283 | 20.902 | 22.983 | 22.708 | 18.337 |
| 股東權益/帶息債務 (%) | 366.711 | 374.754 | 329.079 | 333.256 | 433.349 |
| 股東權益/負債合計 (%) | 257.563 | 243.668 | 239.916 | 234.355 | 276.827 |
| 利息保障倍數 (X) | 11.300 | 8.145 | 5.513 | 6.122 | 5.558 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.097 | 99.521 | 138.243 | 136.316 | 101.316 |
| 存貨周轉天數 (天) | 211.422 | 248.855 | 353.993 | 271.296 | 165.152 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/06/2026 15:32 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
